Half Year Report/Half Year ResultsMEDICLIN reports positive interim results for the first half of 2025 31.07.2025 / 13:13 CET/CESTThe issuer is solely responsible for the content of this announcement.

Symbiosis Reaches Major Milestone with 1,000th Batch of Injectable Drug Product31 July 2025 — Symbiosis Pharmaceutical Services, a global contract manufacturing organisation (CMO), today announced the ...

Overview of Minimally Invasive Surgery MarketThe Global Minimally Invasive Surgery Market is valued at USD 78.5 Billion in ...

The global implantable defibrillator market is projected to grow at a CAGR of ~7% during the forecast period. The growth is ...

The global therapeutic drug monitoring market is expected to grow at a CAGR of around 8% during the forecast period. The ...

The global critical care diagnostics market is set to witness a growth rate of 6% in the next 5 years. Increasing prevalence ...

The global Cancer Pain Market is valued at USD 6983.5 Million in 2024 and is projected to reach a value of USD 12031.1 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 5.1% between 2025 and ...

The global chromatography instruments market is set to witness a growth rate of 5% in the next 5 years. Growing application in pharmaceutical and biotech R&D; growing food safety concerns, ...

Pioneering Dementia Research Site Recognised with Global Site CertificationSouthampton and Maidenhead, UK – 31 July 2025 — The Memory Assessment and Research Centre (MARC), part of the Academy of ...

The global Oral Care Market is valued at USD 42.45 Billion in 2024 and is projected to reach a value of USD 86.8 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.75% between 2025 and 2035.

Legal Matter/Strategic Company DecisionFDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study 31.07.2025 / 06:00 CET/CESTMEDIA RELEASELiestal, Switzerland– Curatis Holding AG (SIX: CURN) – ...

Reduce development timelines and costs, while improving access to life-saving treatments VANCOUVER, BC / ACCESS Newswire / July 30, 2025 / Onco-Innovations Limited (CBOE ...